Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2015 · 10-Q
Revenue$472.80M$472.80M−7.2% vs Q1 2014 Net Income$17.80M$17.80M+165.7% vs Q1 2014 EPS Diluted$0.61$0.61+165.2% vs Q1 2014 Gross Profit$270,100,000−1.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow$29,446,000−55.1% Free Cash Flowderived$2,366,000−94.5% Margins · derivedGross margin57.1%+3.1 pt vs Q1 2014
Operating margin7.3%+3.2 pt vs Q1 2014
Net margin3.8%+2.4 pt vs Q1 2014
ended Mar 31, 2015 · filed May 6, 2015 · 36 d after period end